BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24475232)

  • 1. Affinity improvement of a therapeutic antibody by structure-based computational design: generation of electrostatic interactions in the transition state stabilizes the antibody-antigen complex.
    Kiyoshi M; Caaveiro JM; Miura E; Nagatoishi S; Nakakido M; Soga S; Shirai H; Kawabata S; Tsumoto K
    PLoS One; 2014; 9(1):e87099. PubMed ID: 24475232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
    Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Strategic Residues at the Interface of Antigen-Antibody Interactions by In Silico Mutagenesis.
    Xin L; Yu H; Hong Q; Bi X; Zhang X; Zhang Z; Kong Z; Zheng Q; Gu Y; Zhao Q; Zhang J; Li S; Xia N
    Interdiscip Sci; 2018 Jun; 10(2):438-448. PubMed ID: 28560699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen.
    Wojciak JM; Zhu N; Schuerenberg KT; Moreno K; Shestowsky WS; Hiraiwa M; Sabbadini R; Huxford T
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17717-22. PubMed ID: 19815502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mCSM-AB: a web server for predicting antibody-antigen affinity changes upon mutation with graph-based signatures.
    Pires DE; Ascher DB
    Nucleic Acids Res; 2016 Jul; 44(W1):W469-73. PubMed ID: 27216816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range.
    Yang WP; Green K; Pinz-Sweeney S; Briones AT; Burton DR; Barbas CF
    J Mol Biol; 1995 Dec; 254(3):392-403. PubMed ID: 7490758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial energetic improvement with minimal structural perturbation in a high affinity mutant antibody.
    Midelfort KS; Hernandez HH; Lippow SM; Tidor B; Drennan CL; Wittrup KD
    J Mol Biol; 2004 Oct; 343(3):685-701. PubMed ID: 15465055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of the immunological evolution of antibody 28B4.
    Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG
    Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics and free-energy calculations applied to affinity maturation in antibody 48G7.
    Chong LT; Duan Y; Wang L; Massova I; Kollman PA
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14330-5. PubMed ID: 10588705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics.
    Klarenbeek A; Blanchetot C; Schragel G; Sadi AS; Ongenae N; Hemrika W; Wijdenes J; Spinelli S; Desmyter A; Cambillau C; Hultberg A; Kretz-Rommel A; Dreier T; De Haard HJ; Roovers RC
    Protein Eng Des Sel; 2016 Apr; 29(4):123-33. PubMed ID: 26945588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light chain somatic mutations change thermodynamics of binding and water coordination in the HyHEL-10 family of antibodies.
    Acchione M; Lipschultz CA; DeSantis ME; Shanmuganathan A; Li M; Wlodawer A; Tarasov S; Smith-Gill SJ
    Mol Immunol; 2009 Dec; 47(2-3):457-64. PubMed ID: 19781789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in therapeutic antibody affinity maturation: From in-vitro towards next-generation sequencing approaches.
    Tabasinezhad M; Talebkhan Y; Wenzel W; Rahimi H; Omidinia E; Mahboudi F
    Immunol Lett; 2019 Aug; 212():106-113. PubMed ID: 31247224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-guided library generation applied to the optimization of single-domain antibodies.
    Akiba H; Tamura H; Caaveiro JMM; Tsumoto K
    Protein Eng Des Sel; 2019 Dec; 32(9):423-431. PubMed ID: 32167147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation.
    Furukawa K; Manabe A; Furukawa A; Kuba H; Okajima T; Azuma T
    Mol Immunol; 2006 Apr; 43(11):1751-60. PubMed ID: 16406527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational design of antibody-affinity improvement beyond in vivo maturation.
    Lippow SM; Wittrup KD; Tidor B
    Nat Biotechnol; 2007 Oct; 25(10):1171-6. PubMed ID: 17891135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding.
    Koenig P; Lee CV; Walters BT; Janakiraman V; Stinson J; Patapoff TW; Fuh G
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E486-E495. PubMed ID: 28057863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formation.
    Addis PW; Hall CJ; Bruton S; Veverka V; Wilkinson IC; Muskett FW; Renshaw PS; Prosser CE; Carrington B; Lawson ADG; Griffin R; Taylor RJ; Waters LC; Henry AJ; Carr MD
    J Biol Chem; 2014 Mar; 289(10):7200-7210. PubMed ID: 24436329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.